Bridgebio Pharma, Inc.
US
Bridgebio Pharma, Inc.: 2 links from the documents of the companies and the register.
Customers 2
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| Bristol-Myers Squibb Company | 80.6% of the revenue of the supplier, fiscal year ended 31 Dec 2023 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
| Kyowa Kirin Co., Ltd | 34.3% of the revenue of the supplier, fiscal year ended 31 Dec 2024 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
Each link names the documents that state it, with the class of its evidence: stated by one party, confirmed by both, or stated by the register of legal entities. A commitment is the commitment at the date of the agreement.